vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and BRC Group Holdings, Inc. (RILY). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $188.3M, roughly 1.1× BRC Group Holdings, Inc.). BRC Group Holdings, Inc. runs the higher net margin — 47.9% vs 2.7%, a 45.3% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -21.9%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -15.4%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
IRTC vs RILY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $188.3M |
| Net Profit | $5.6M | $90.3M |
| Gross Margin | 70.9% | 79.5% |
| Operating Margin | 1.1% | 32.3% |
| Net Margin | 2.7% | 47.9% |
| Revenue YoY | 27.1% | -21.9% |
| Net Profit YoY | 518.5% | 1710.8% |
| EPS (diluted) | $0.18 | $2.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $188.3M | ||
| Q3 25 | $192.9M | $215.3M | ||
| Q2 25 | $186.7M | $188.2M | ||
| Q1 25 | $158.7M | $197.2M | ||
| Q4 24 | $164.3M | $241.0M | ||
| Q3 24 | $147.5M | $225.5M | ||
| Q2 24 | $148.0M | $256.0M | ||
| Q1 24 | $131.9M | $263.4M |
| Q4 25 | $5.6M | $90.3M | ||
| Q3 25 | $-5.2M | $91.1M | ||
| Q2 25 | $-14.2M | $139.5M | ||
| Q1 25 | $-30.7M | $-10.0M | ||
| Q4 24 | $-1.3M | $-5.6M | ||
| Q3 24 | $-46.2M | $-284.4M | ||
| Q2 24 | $-20.1M | $-433.6M | ||
| Q1 24 | $-45.7M | $-49.2M |
| Q4 25 | 70.9% | 79.5% | ||
| Q3 25 | 71.1% | 83.7% | ||
| Q2 25 | 71.2% | 81.3% | ||
| Q1 25 | 68.8% | 81.4% | ||
| Q4 24 | 70.0% | 79.8% | ||
| Q3 24 | 68.8% | 82.1% | ||
| Q2 24 | 69.9% | 84.5% | ||
| Q1 24 | 66.3% | 85.3% |
| Q4 25 | 1.1% | 32.3% | ||
| Q3 25 | -4.4% | 30.4% | ||
| Q2 25 | -10.0% | 5.7% | ||
| Q1 25 | -20.5% | -31.2% | ||
| Q4 24 | -2.5% | -69.2% | ||
| Q3 24 | -34.1% | -36.4% | ||
| Q2 24 | -15.5% | -90.8% | ||
| Q1 24 | -28.9% | -6.1% |
| Q4 25 | 2.7% | 47.9% | ||
| Q3 25 | -2.7% | 42.3% | ||
| Q2 25 | -7.6% | 74.1% | ||
| Q1 25 | -19.3% | -5.1% | ||
| Q4 24 | -0.8% | -2.3% | ||
| Q3 24 | -31.3% | -126.1% | ||
| Q2 24 | -13.6% | -169.4% | ||
| Q1 24 | -34.6% | -18.7% |
| Q4 25 | $0.18 | $2.78 | ||
| Q3 25 | $-0.16 | $2.91 | ||
| Q2 25 | $-0.44 | $4.50 | ||
| Q1 25 | $-0.97 | $-0.39 | ||
| Q4 24 | $-0.03 | $-0.01 | ||
| Q3 24 | $-1.48 | $-9.39 | ||
| Q2 24 | $-0.65 | $-14.35 | ||
| Q1 24 | $-1.47 | $-1.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $226.6M |
| Total DebtLower is stronger | — | $1.4B |
| Stockholders' EquityBook value | $152.7M | $-171.5M |
| Total Assets | $1.0B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $226.6M | ||
| Q3 25 | $565.2M | $184.2M | ||
| Q2 25 | $545.5M | $267.4M | ||
| Q1 25 | $520.6M | $138.3M | ||
| Q4 24 | $535.6M | $146.9M | ||
| Q3 24 | $522.0M | $159.2M | ||
| Q2 24 | $561.5M | $236.9M | ||
| Q1 24 | $569.1M | $190.7M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $152.7M | $-171.5M | ||
| Q3 25 | $121.9M | $-260.5M | ||
| Q2 25 | $103.7M | $-351.7M | ||
| Q1 25 | $86.7M | $-496.8M | ||
| Q4 24 | $90.9M | $-488.2M | ||
| Q3 24 | $71.8M | $-497.6M | ||
| Q2 24 | $99.2M | $-218.3M | ||
| Q1 24 | $90.3M | $228.4M |
| Q4 25 | $1.0B | $1.7B | ||
| Q3 25 | $995.2M | $1.7B | ||
| Q2 25 | $964.0M | $1.5B | ||
| Q1 25 | $926.1M | $1.5B | ||
| Q4 24 | $931.4M | $1.8B | ||
| Q3 24 | $909.7M | $2.2B | ||
| Q2 24 | $919.2M | $3.2B | ||
| Q1 24 | $909.8M | $5.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $26.2M |
| Free Cash FlowOCF − Capex | $14.5M | — |
| FCF MarginFCF / Revenue | 6.9% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | 4.70× | 0.29× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $26.2M | ||
| Q3 25 | $34.9M | $-60.6M | ||
| Q2 25 | $27.7M | $-25.6M | ||
| Q1 25 | $-7.9M | $184.0K | ||
| Q4 24 | $19.2M | $-2.7M | ||
| Q3 24 | $24.3M | $19.5M | ||
| Q2 24 | $11.8M | $111.5M | ||
| Q1 24 | $-52.0M | $135.4M |
| Q4 25 | $14.5M | — | ||
| Q3 25 | $20.1M | — | ||
| Q2 25 | $17.3M | — | ||
| Q1 25 | $-17.3M | — | ||
| Q4 24 | $12.4M | — | ||
| Q3 24 | $15.5M | — | ||
| Q2 24 | $3.4M | — | ||
| Q1 24 | $-61.8M | — |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | -10.9% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | -46.8% | — |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 5.9% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 5.7% | — | ||
| Q1 24 | 7.4% | — |
| Q4 25 | 4.70× | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
